-
-
-
-
-
-
-
NextCure (NXTC) and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6
-
-
-
-
-
-
-
NextCure Inc. (NXTC) Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

